The 28 Billion Dollar Reason Heart Health Matters in Women Post-menopause
Cardiovascular disease (CVD) remains the leading cause of death among women, yet it is often misdiagnosed and/or undertreated in this population. About 80% of women ages 40 to 60 have one or more risk factors for CVD, including hormonal shifts that occur during menopause. During this time, weight distribution shifts, metabolism slows down, and stress levels tend to increase. Despite these significant health implications, menopause and its effects on women's health are often not discussed openly, contributing to the broader challenges within the healthcare system where specific cardiovascular risks faced by aging women are understudied and may be minimized or misunderstood.
Join Omada Health’s Chief Medical Officer Carolyn Jasik, MD, and Midi Health’s Chief Executive Officer Joanna Strober for a conversation that breaks the silence on why heart health in women, particularly as they navigate through menopause, warrants more attention, discussion, and tailored healthcare approaches.
Specifically, they will cover the following:
-
Why heart health becomes increasingly critical for women as they age
-
How metabolic changes during menopause elevate cardiovascular risk among women
-
How informed, empathetic, and personalized healthcare solutions can effectively address the distinctive challenges and risks prevalent among women
Carolyn Jasik, MD
Chief Medical Officer, Omada Health
Carolyn is a board-certified physician with a career spanning health technology startups, multidisciplinary care, education, and research associateships. Carolyn previously spent 14 years with the University of California as an Associate Professor of Pediatrics and Clinical Instructor at San Francisco General Hospital. She completed her Medical Degree at the University of Chicago’s Pritzker School of Medicine and her research training at the University of California, San Francisco. At Omada, Carolyn supports the clinical and research teams to create and test the next generation of integrated chronic disease care programming via digital therapeutics.
CEO, Midi Health
Joanna is the founder of Midi, a virtual care platform for women in perimenopause and menopause. Prior to founding Midi, Joanna founded Kurbo, the first digital therapeutic for childhood obesity, scaled to help tens of thousands of children and sold to Weight Watchers in 2018. Joanna spent 20+ years in direct private equity and venture capital investing in health and consumer companies. She is the author of the book Getting to 50/50, a primer on how women can thrive at work and home. Recently named to the Forbes 50 over 50 list of top Innovators in 2023.